CPC A61K 47/66 (2017.08) [A61K 47/64 (2017.08); A61K 47/69 (2017.08); A61K 47/6901 (2017.08); A61K 47/6911 (2017.08); A61K 47/6929 (2017.08); A61K 47/6953 (2017.08); A61K 49/0002 (2013.01); A61K 49/0056 (2013.01); C12N 15/113 (2013.01); C12N 2310/14 (2013.01); C12N 2310/3513 (2013.01)] | 13 Claims |
1. A therapeutic composition, comprising:
a peptide segment which is SEQ ID NO. 2 and pharmaceutically acceptable salts or esters thereof; and
a cysteine residue at the N-terminus or C-terminus of the peptide segment.
|